Agenus Inc insider trades: MiNK Therapeutics (INKT) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Agenus Inc reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 16, 2023 | INKT | ↑ Buy | 22,975 | $1.10 | $25K | Direct | Oct 16, 2023 (0d) |
| Oct 4, 2023 | INKT | ↑ Buy | 15,001 | $1.09 | $16K | Direct | Oct 6, 2023 (2d) |
| Aug 29, 2023 | INKT | ↑ Buy | 29,678 | $1.52 | $45K | Direct | Aug 31, 2023 (2d) |
| Aug 28, 2023 | INKT | ↑ Buy | 183,052 | $1.54 | $281K | Direct | Aug 28, 2023 (0d) |
| May 11, 2023 | INKT | ↑ Buy | 45,426 | $1.47 | $67K | Direct | May 12, 2023 (1d) |
| May 5, 2023 | INKT | ↑ Buy | 250,362 | $1.04 | $260K | Direct | May 5, 2023 (0d) |
| Oct 19, 2021 | INKT | ↑ Buy | 1,400,000 | $12.00 | $16.8M | Direct | Oct 20, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other INKT insiders
Open-market trades in the last 12 months
About Agenus Inc's insider trades
Agenus Inc is an insider at MiNK Therapeutics (INKT). Since Oct 19, 2021, it has reported 7 open-market purchases worth $17.5M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INKT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.